| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3333325 | Revue d'Oncologie Hématologie Pédiatrique | 2014 | 8 Pages |
Abstract
In this study, congenital acute lymphoblastic leukemia appeared to occur earlier and to be more severe than in clinical trials where infants were included selectively. This extremely poor prognosis requires including ethical considerations in the therapeutic strategy, aiming to preserve the comfort of the child and to support attachment behavior or grieving process for the parents and family.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Y. Huguenin, W. Abouh Chahla, C. Vérité, P. Blouin, Y. Perel, J.Clavel J.Clavel, Y. Bertrand, G. Michel, T. Leblanc, C. Thomas, N. Sirvent, B. Nelken, J.L. Stephan, D. Plantaz, V. Gandemer, G. Couillault, E. Plouvier, M. Munzer, G. Leverger,